457 results about "Molecular probe" patented technology

The invention is applicable to the technical field of pathological analysis, and provides a biological sample pathological detection method and system based on a characteristic signal threshold, and the detection system comprises: a molecular probe labeling module for performing molecular probe labeling on a standard sample and a biological sample to be detected; the three-dimensional gel electrophoresis device is used for carrying out three-dimensional gel electrophoresis separation on the marked sample; the three-dimensional gel electrophoresis signal collection module is used for extracting and collecting sample signals after electrophoretic separation; the tissue characteristic signal threshold establishing module is used for establishing a characteristic signal threshold of the standard sample; and the automatic diagnosis module is used for detecting the biological sample to be detected by utilizing the established characteristic signal threshold. The biological sample pathology detection method based on the characteristic signal threshold value shows excellent performance in clinical pathology detection, the clinical pathology work burden can be relieved, the clinical pathology work accuracy can be improved, and the biological sample pathology detection method has wide application prospects and huge market potential.

The invention discloses a molecular probe for in-vivo copper ion detection and a preparation method and application thereof, the chemical structural formula of the molecular probe is as follows: # imgabs0 #, the molecular probe provided by the invention can specifically respond to copper ions in a tumor subacid environment so as to cause change of an absorption spectrum, and a photoacoustic signal is started so as to detect the copper ions in the tumor subacid environment. Normal tissues and tumor tissues can be accurately distinguished, and accurate detection of the copper ions in the living tumor is realized.

The invention relates to the technical field of coal bed gas resource exploration, in particular to a coal rock methane adsorption quantity correction method based on a coal macromolecular model, which comprises the following steps: characterizing coal rock physicochemical properties; constructing a three-dimensional coal macromolecular model by utilizing molecular dynamics simulation, and verifying the coal macromolecular model; detecting the free space volume of the model by adopting a molecular probe method; performing a volumetric method coal rock methane adsorption test; determining the free space volume change under the series of test pressures through helium; and replacing the coal rock free space volume measured by helium with the coal rock free space volume measured based on a methane probe in molecular simulation so as to correct the methane adsorption isotherm. The method solves the problem that accurate determination and dynamic change of the free space volume are not considered in an existing volumetric method isothermal adsorption test.

The invention relates to a radionuclide-labeled glucose derivative molecular probe and application thereof, and belongs to the technical field of nuclear medicine. According to the present invention, propargyl glycine is used to synthesize an amino acid skeleton, and the amino acid skeleton reacts with glucose azide to prepare a series of radionuclide-labeled glucose derivative molecular probes, such as [68Ga] Ga-NOTA-SDG, [68Ga] Ga-NOTA-DDG, [68Ga] Ga-NOTA-TDG, [68Ga] Ga-DOTA-SDG, [68Ga] Ga-DOTA-DDG and the like; the glucose derivative molecular probe labeled by the series of radionuclides has the advantages of being simple and rapid in labeling, high in radiolabeling yield and good in stability, can accurately position tumors, has good tumor uptake and lower non-target tissue uptake, and has great application prospects in preparation of broad-spectrum tumor imaging agents.

The invention discloses an ultrasonic molecular probe. The ultrasonic molecular probe comprises a targeted contrast agent and siRNA of fibronectin, wherein the targeted contrast agent and the siRNA are connected through G0-C14; the targeted contrast agent comprises gas vesicles covalently linked with annular polypeptide, and the annular polypeptide targets an atherosclerotic plaque region. The cyclic polypeptide can be combined with the outer structural domain B of fibronectin with high specificity, and the atherosclerotic plaque extracellular matrix is rich in the outer structural domain B of the fibronectin, so that enough targeted ultrasonic contrast agent can be quickly combined in the plaque region to generate strong signal enhancement in ultrasonic imaging, and on the basis, the targeted ultrasonic contrast agent can be quickly combined with the plaque region to generate strong signal enhancement in ultrasonic imaging. The ultrasonic molecular probe releases siRNA for atherosclerotic plaque treatment, and atherosclerotic plaque diagnosis and treatment integration is achieved. The invention further discloses a preparation method of the ultrasonic molecular probe and application of the ultrasonic molecular probe in preparation of atherosclerotic plaque diagnostic agents, drugs and drug delivery agents.

The invention discloses a radionuclide labeled molecular probe for detecting collagen structure denaturation and a preparation method and application thereof, and relates to the technical field of biology. The structural general formula of the radionuclide labeled molecular probe disclosed by the invention is as follows: K (chelating agent-nuclide)-K-Linker-CHP, wherein K (chelating agent-nuclide) is a lysine residue labeled by a side chain amino coupling chelating agent and a radionuclide; the Linker is a connection joint; cHP is a collagen hybrid peptide with a polypeptide sequence of (GfO) n or (GPO) n. The probe has excellent definition and signal-to-noise ratio, not only can detect pancreatic ductal adenocarcinoma in a pancreatic cancer model, but also can sensitively detect precancerous lesions (such as pancreatic intraepithelial neoplasia lesions) of the pancreatic ductal adenocarcinoma and pulmonary fibrosis lesions in a bleomycin pulmonary fibrosis model. And the kit has important significance on early detection of pancreatic duct adenocarcinoma and reflection of dynamic change of ECM remodeling.

The use of an SNP site combination of Litopenaeus vannamei in trait evaluation of mixed-family culture, a probe and a kit. The SNP site combination of Litopenaeus vannamei comprises 1125 SNP sites, wherein the physical positions are determined on the basis of alignment with a reference genome sequence of Litopenaeus vannamei. Also disclosed are a molecular probe for capturing the SNP site combination and a kit comprising the molecular probe. By means of using the SNP site combination for paternity identification, the present invention can achieve the mixed culture of individuals of different families in the early stage, so that the common environmental effect caused by separate family culture in the early stage is effectively reduced, and the accuracy of a trait evaluation result of mixed culture is improved; moreover, the genetic relationship between individuals can be accurately calculated. Compared with physical marks, the present invention avoids the phenomena of falling and dislocation of marks on individuals and human identification errors, thus obtaining accurate pedigrees.

The invention discloses an indole sophocarpidine derivative photoaffinity active molecular probe which is formed by connecting an active group and a reactive group, the active group is a sophocarpidine derivative, the reactive group is a substance containing a diaziridine group and an alkyne group, and the chemical formula of the sophocarpidine derivative is as shown in the formula I. The invention further discloses a preparation method of the indole sophocarpidine derivative photoaffinity active molecular probe. After Spodoptera frugiperda Sf9 cells are treated by the indole sophocarpidine derivative photoaffinity active molecular probe for 72 hours, the inhibition rate can reach 86.33%, potential target protein when the sophocarpidine derivative acts on the Sf9 cells can be determined by utilizing the indole sophocarpidine derivative photoaffinity active molecular probe, targeted modification of sophocarpidine is facilitated, and the application range of the indole sophocarpidine derivative photoaffinity active molecular probe is widened. Further, matrine pesticides with excellent insecticidal activity are efficiently synthesized, and agricultural pests are better prevented and controlled.

The invention belongs to the technical field of molecular probes and nano textile materials, and particularly relates to a fluorescent probe for detecting metal palladium, a fluorescent nanofiber membrane and a preparation method and application of the fluorescent nanofiber membrane. The fluorescent probe for detecting metal palladium provided by the invention takes benzopyran as a fluorescent parent nucleus and allyl as a recognition site, is novel in structure, and can realize effective detection of elemental palladium in the environment. Furthermore, according to the fluorescent nanofiber membrane for detecting the metal palladium, the electrostatic spinning technology and the fluorescent probe are effectively combined, and rapid detection of the elemental palladium can be achieved through the fluorescence opening performance after the fluorescent probe reacts with the metal palladium. Besides, the fluorescent nanofiber membrane has the characteristics of simplicity in preparation, low cost and reusability, can provide a powerful tool for rapid, simple and convenient detection of palladium-containing elementary substance pollutants in the environment, and has an extremely wide application prospect in the field of metal palladium detection.

The invention provides an SNP (Single Nucleotide Polymorphism) molecular marker combination, a molecular probe combination, a liquid phase chip and a kit for corn genotyping and application of the SNP molecular marker combination, the molecular probe combination, the liquid phase chip and the kit, and belongs to the technical field of gene chips. The SNP molecular marker combination and the liquid chip provided by the invention can be used for efficient and rapid genetic typing of corn germplasm resources, and are low in cost and suitable for corn biological breeding. The SNP marker provided by the invention uniformly covers the whole corn reference genome, provides a high-quality molecular marker for silage corn whole genome selective breeding, and can also be used for map-based cloning of important agronomic trait genes of silage corn.

The invention discloses a double-recognition fluorescent molecular probe, a preparation method thereof and application of the double-recognition fluorescent molecular probe in detection of lead ions and / or glyphosate, and relates to the technical field of detection of lead ions and pesticide glyphosate. The double-recognition fluorescent molecular probe disclosed by the invention is a Schiff base type probe which takes dicyanoisophorone and benzoyl hydrazine as fluorophores. The invention also relates to application of the double-recognition fluorescent molecular probe in lead ion sensing detection. The complex of the double-recognition fluorescent molecular probe and lead ions can be used for sensing detection of glyphosate. The double-recognition fluorescent molecular probe provided by the invention has the advantages of easily available raw materials and simple operation. According to the present invention, the quantitative detection of the lead ions / or the glyphosate by the probe through the different functions displayed by the ultraviolet and fluorescence spectra is achieved, the reversibility is strong, the multi-time cyclic utilization can be achieved, the selectivity is good, the influence by other metal ions is not easily generated, the detection limit is low, and the excellent application imaging is provided in animal bodies such as cells, zebra fish and the like.

The invention relates to the field of molecular imaging, in particular to a molecular probe targeting GPC3. The invention claims to protect a molecular probe targeting GPC3, the molecular probe is a compound having the following sequence, or a pharmaceutically acceptable salt or ester thereof: (GPC3 antibody, including antibody fragment of GPC3 antibody, or single domain antibody thereof) m-Rn, where R is selected from a linking group, a chelating agent, a radionuclide, another targeting polypeptide or monoclonal antibody, monoclonal antibody fragment, single domain antibody, and Rn is selected from a linking group, a chelating agent, a radionuclide, another targeting polypeptide or monoclonal antibody, a monoclonal antibody fragment, and a single domain antibody. And a group consisting of small molecule inhibitors; wherein n represents the number of R, and n is equal to 0-4; wherein m is not 0. The probe has good in-vitro stability, can be clearly developed in tumors, and has good specificity.

The invention belongs to the technical field of gene detection and gene molecular breeding, and particularly relates to a meat duck whole genome molecular probe combination based on molecular phenotype screening, a 50K gene chip and application thereof. The molecular probe combination and the gene chip of the marker site combination for meat duck whole genome breeding simultaneously cover 7 representative meat duck varieties and 71 economic characters, have richer polymorphism and higher pertinence in meat duck groups, and are lower in cost and higher in speed compared with high-throughput sequencing detection; the breeding chip is designed according to the growth, feed efficiency, slaughtering, breeding, egg quality and various molecular phenotypes of the meat ducks, and compared with a high-throughput sequencing technology, the breeding chip is higher in seed selection accuracy, has higher breeding value, can be widely applied to breeding genotype detection of the meat ducks, and can be used for detecting the breeding genotypes of the meat ducks. And the method has creative significance in the aspect of meat duck genome selective breeding.

The invention discloses a molecular marker combination for analyzing goat varieties and application, relates to the technical field of biology, and provides 13947 molecular markers capable of analyzing goats, and the physical position information of the molecular markers is determined based on genome sequence comparison of a goat reference genome ARS1.2. A molecular probe combination, a gene chip and a kit prepared from 13947 SNP molecular markers can be used for carrying out genetic evaluation on goat individuals, carrying out individual selection on goat varieties which are difficult to determine in the early stage, shortening the generation interval and accelerating the breeding process, so that a large amount of breeding cost is saved.

The invention discloses a tumor targeting reagent and application thereof in tumor diagnosis. The targeting reagent has strong affinity to tumors, strong specificity and no biotoxicity, is relatively stable in vivo, and can be used as a molecular probe to be applied to molecular imaging and / or treatment of various integrin alpha6 high-expression tumors; the targeting reagent provided by the invention comprises the tumor targeting peptide RWYDeA, and further comprises a radionuclide chelating agent, other connecting structures and a hydroxyl substitution structure, and the structure is beneficial to improving the tumor targeting property of the targeting reagent, prolonging the tumor binding time and achieving a better tumor diagnosis effect; the method can be used for preparing products for diagnosing / treating diseases related to high expression of integrin alpha6.

The application relates to a DNAzyme-based gene chip biosensor and application thereof, and belongs to the technical field of electrochemical sensors. In order to solve the technical problems of low specificity and accuracy, long processing time and high cost in the single nucleotide polymorphism detection method in the prior art, a DNAzyme-based gene chip biosensor is provided, which comprises a DNAzyme molecular probe SNP recognition system and a solid-liquid phase mixed catalytic network system. The application provides a proteinase-free and space-oriented biosensing strategy, utilizes a molecular switch based on a DNAzyme probe to realize accurate SNP recognition, utilizes a space steric hindrance parallel amplification system to enhance signal amplification and simultaneously inhibit background noise, so that the detection performance is remarkably improved; and the gene chip biosensor can be applied to genotyping and trait selection in crop improvement and other applications.

The invention relates to an oxidase response type molecular probe as well as a preparation method and application thereof, and belongs to the technical field of medical imaging. Aiming at the problem that the inflammation activity is difficult to accurately evaluate in the prior art, the invention provides a molecular imaging probe capable of responding to the activity of in-vivo myeloperoxidase (MPO), and the molecular imaging probe can be used for real-time and non-invasive imaging monitoring of the activity of the in-vivo MPO, so that the activity of the inflammatory reaction of a focus is accurately evaluated. The invention provides a chelating agent with structural characteristics of a chelating unit and an enzyme response unit, and is characterized in that the enzyme response molecular probe is constructed by taking rigid framework cyclohexanediamine (CDTA) as a transition metal chelating unit and taking electron-rich functional groups (such as phenol, catechol or 5-hydroxytryptamine) as the enzyme response unit. The probe is chelated with paramagnetic metal (such as Mn < 2 + >) for magnetic resonance imaging (MRI) or radioactive metal (such as 68Ga) for positron emission tomography (PET), so that specific response to MPO activity is realized. The dynamic stability of the probe is remarkably improved; after the MPO is responded, the relaxation efficiency is improved by 2-3 times, and the sensitivity is optimized; the cytotoxicity is low; in an acute pancreatitis model, the MRI contrast noise ratio (delta CNR) reaches 77.39 + / -7.04 and is 4.2 times that of a control group, the PET uptake rate is remarkably improved, bimodal imaging is supported, and accurate positioning and quantitative evaluation of the inflammation activity are achieved.

The invention relates to a specific PET molecular probe of a targeted KRASG12D mutant as well as a preparation method and application of the specific PET molecular probe. Pyridopyrimidine compounds and R5 are subjected to cooling reaction under the action of N, N-diisopropylethylamine to generate a compound 2; the compound 2 and (2-fluorotetrahydro-1H-pyrrolizine-7A (5H)-yl) methanol are subjected to a heating reaction under the action of N, N-diisopropylethylamine, and a compound 3 is generated; carrying out heating reaction on the compound 3 and biphenyl boronic acid pinacol ester under the action of N, N-diisopropylethylamine and tetrakis (triphenylphosphine) palladium to generate a compound 4; carrying out heating reaction on the compound 4 and 1, 2-bis (tolyloxy) alkane under the action of potassium carbonate to generate a compound 5; the compound 5, radioisotope < 18 > F and an anion complexing agent are subjected to a heating reaction under the action of potassium carbonate to generate the trisubstituted pyridopyrimidine < 18 > F labeled PET molecular probe. Compared with the prior art, the kit has a positioning diagnosis effect on KRASG12D mutant tumors, and image typing of mutant and non-mutant tumors and pathological evaluation after tumor treatment are realized at the same time.

The invention relates to a molecular probe for targeting a prostate specific membrane antigen and application, and belongs to the technical field of nuclear medicine. The invention provides a molecular probe for targeting a prostate specific membrane antigen, and the molecular probe successfully obtains a PSMA targeting molecular probe by introducing iodobenzene butyric acid and a PEG4 group on the basis of a PSMA-617 molecular structure on the basis of a double-ligand covalent coupling technology. The molecular probe has the advantages that the residence time of the molecular probe in a tumor area is obviously prolonged, the treatment effect is improved, the requirement for radioactive dose is reduced, and radiation damage to surrounding normal tissues is reduced; the specificity is excellent, a tumor area with high PSMA expression can be accurately targeted, and tumors with different PSMA expression levels can be effectively distinguished; the speed of reaching a target tumor is high, and an ideal imaging effect can be realized only in 20 minutes. In conclusion, the molecular probe has great advantages in diagnosis and treatment of PSMA high-expression tumors, and has high specificity and high efficiency.

The invention discloses a nano antibody targeting GPRC5D as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The nano antibody is generated by mixed immunization of a GPRC5D polypeptide antigen with a sequence shown as SEQ ID NO: 1 and a GPRC5D protein antigen with a sequence shown as SEQ ID NO: 2. The preparation method comprises the following steps: mixing the GPRC5D polypeptide antigen and the GPRC5D protein antigen to immunize alpaca, sampling blood, constructing an antibody library, screening a phage display antibody library, expressing protein, and selecting the nano antibody with the highest affinity. The invention further provides a radionuclide labeled molecular probe, the nano antibody is small in molecular weight and can recognize a large number of epitopes, and the molecular probe prepared from the nano antibody can obtain high-quality images, is used for preparing products for developing multiple myeloma or detecting GPRC5D expression level and has wide application prospects.

The present disclosure pertains to the biological field, specifically to a combination of 33 single nucleotide polymorphism (SNP) loci associated with the wool fiber diameter of fine wool sheep, determined using Ovis aries reference genome version 4.0. It also covers the use of reagents for detecting genotypes of these SNP loci in wool fiber diameter analysis or molecular marker-assisted selection of fine wool sheep. Additionally, it includes molecular probe combinations, gene chips, and kits based on the SNP loci. These tools facilitate early-stage wool fiber trait analysis, enabling individual selection, reducing generation intervals, accelerating breeding processes, and lowering costs. This disclosure provides crucial support for the identification, breed preservation, and molecular genetic breeding of fine wool sheep.

The invention discloses a bifunctional fluorescent molecular probe, a preparation method thereof and application of the bifunctional fluorescent molecular probe in polarity detection of ONOO <-> and lipid droplets, and belongs to the technical field of polarity detection of ONOO <-> and lipid droplets. The problems that a fluorescent probe is only limited to detection of a single analyte, and targeted monitoring of lipid droplets in cells and simultaneous detection of endogenous ONOO <-> in the cells cannot be achieved are solved. According to the invention, a dual-response fluorescent molecular probe PTQ based on a triphenylamine group is prepared, and the PTQ shows dual response to a polar environment and dynamic change of ONOO <->. Test results show that the fluorescent probe shows high sensitivity (1.92 nM), stable fluorescence signals and high quantum yield (57.76%) in a low-polarity medium, also has excellent ONOO <-> selectivity, low detection limit (4.97 nM), low toxicity and excellent biological imaging ability, and realizes targeted monitoring of lipid droplets and detection of endogenous ONOO <-> in cells.

The invention discloses a boron difluoride curcumin skeleton compound as shown in a formula (I), and belongs to the field of medical imaging molecular probes. The boron difluoride curcumin skeleton compound disclosed by the invention has the characteristics of near-infrared emission and large Stokes shift, can be used as a fluorescent probe for marking key pathological proteins such as beta-amyloid protein (Abeta) aggregate of Alzheimer's disease (AD) and the like, and has the characteristics of high sensitivity, high signal-to-noise ratio and high imaging; in addition, in-vivo level A beta imaging can be realized through a blood brain barrier. The boron difluoride curcumin skeleton compound disclosed by the invention also has a treatment effect and can be used for remarkably inhibiting A beta monomers from forming aggregates and depolymerizing A beta aggregates, and meanwhile, the compound shown as the formula (I) is used for remarkably inhibiting A beta-induced microglial cell inflammatory response. The invention also provides a preparation method of the boron difluoride curcumin skeleton compound, an intermediate compound and application of the boron difluoride curcumin skeleton compound. # imgabs0 #

The invention relates to a small molecular probe TPE-J based on fluorescence sensing and application thereof. According to the intelligent real-time monitoring system for the nitro explosive, a PPYOLO algorithm is utilized, and a fluorescent colorimetric image is captured under the assistance of an optical camera. The fluorescent probe TPE-J is designed and synthesized and is used for dose sensitivity and visual detection of nitro explosives. Electron transfer between PA and the probe causes specific response, original blue fluorescence is rapidly quenched to be non-luminous within 5 seconds, and the detection limit is as low as 1 mg / mL. Color changes can be integrated into optical camera capture and quantization, and generated image data is automatically processed by a deep learning algorithm platform. The sensing system is beneficial to efficient real-time monitoring and high-sensitivity PA detection in various scenes. A fluorescence sensing detection platform combined with deep learning provides a new visual angle for efficient and portable detection of explosives.

The invention provides an image processing method and device for early detection of Alzheimer's disease, a storage medium and equipment. The image processing method comprises the following steps: an image acquisition stage: acquiring a brain 1H magnetic resonance anatomical image of a tester before taking a labeled probe and acquiring a brain 2H magnetic resonance metabolism image set of the tester within a preset time period after taking the labeled probe; an image processing stage: performing magnetic resonance signal quantitative estimation according to the brain 2H magnetic resonance metabolism image set to obtain a metabolic flux characteristic quantitative image set, and registering the metabolic flux characteristic quantitative image set to the brain 1H magnetic resonance anatomical image to obtain a training sample; and a model training stage: training a preset diagnosis model by the training sample, wherein the diagnosis model is a feature pyramid deep learning model based on Context Transform Block. Metabolic flux characteristic changes of AD in the early stage can be captured, dynamic injection and multi-period continuous scanning of the molecular probe are marked, and long-term tracking is achieved.

The invention belongs to the technical field of fluorescent probes and supramolecules, and particularly relates to an organic small molecule fluorescent probe for lithium ion detection as well as a synthesis method and application of the organic small molecule fluorescent probe. Aiming at the problems that an existing fluorescent probe for identifying Li < + > is easily influenced by pH and interfered by coexisting metal ions, and is poor in water solubility, low in sensitivity, poor in selectivity and the like, the crown ether fluorescent molecular probe for detecting the lithium ions is 4-aza-12-crown-4-ether-7-nitrobenzofuran; the compound is prepared from 4-chloro-7-nitrobenzofuran and aza 12-crown-4-ether in a substitution manner. The fluorescent probe has the advantages that 1) the structure is simple, the preparation is easy, and excitation and emission wavelengths are in a visible light region; 2) good water solubility is achieved; 3) the material has good selectivity on lithium ions; 4) the method has the advantages of high sensitivity, quick response and the like in lithium ion detection, and can be used for in-situ-real-time detection of lithium ions; and (5) the cell toxicity is low, and the biocompatibility is good.

The invention relates to a carbonic anhydrase IX targeted molecular probe and application thereof, and belongs to the technical field of nuclear medicine. The invention provides carbonic anhydrase IX targeted molecular probes 18F-SAZ and 18F-DAZ, and the two molecular probes have the following advantages: firstly, the specificity is strong, and the molecular probes can be selectively taken in a CAIX positive tumor part so as to better distinguish carbonic anhydrase IX negative and positive tumors; secondly, the compound can quickly reach a carbonic anhydrase IX positive tumor, a better imaging effect can be obtained within 30 minutes, and the compound has better retention property; and thirdly, the in-vivo metabolism is rapid, the biological half-life period is shorter, the in-vivo clearing time is obviously shorter than that of an antibody molecular probe, and the safety is higher. In conclusion, the two molecular probes can dynamically monitor the change of the level of carbonic anhydrase IX in tumor cells in real time through PET imaging, and have great application prospects in diagnosis of positive tumors of carbonic anhydrase IX.

The invention discloses a tumor treatment molecule with a curative effect self-amplification function. Belongs to the technical field of biotechnology and new medicine, and comprises a peptide sequence Ac-Asp-Glu-Val-Asp-Cys (StBu)-Lys combined to a CBT part and a paclitaxel chemotherapy molecule connected to a lysine side chain. After the probe enters a tumor cell, the probe is specifically recognized by reducing glutathione highly expressed in the tumor cell, and an Ac-DEVDCK (PTX)-CBT structure is generated; then, a weak cell apoptosis phenomenon is initiated through a molecular grafted paclitaxel structure; the Ac-DEVD fragment is used as a high-specificity polypeptide substrate of cysteine-aspartic acid specific protease 3 which is necessary in a cell apoptosis pathway, and can be specifically cut by the cysteine-aspartic acid specific protease 3, so that the Ac-DEVDCK (PTX)-CBT is converted into CK (PTX)-CBT; then, CK (PTX)-CBT molecules are subjected to a CBT-Cys click reaction to form a cyclic dimer, and the cyclic dimer is self-assembled to form particles. According to the method, the affinity of the paclitaxel to the tubulin in the cytoskeleton is utilized, so that the tubulin in the cell is aggregated, the self-amplification effect of the curative effect of the cell is realized, and the cell is triggered to generate a pan-apoptosis effect.

The invention discloses a molecular marker combination for analyzing varieties of milk goats and application of the molecular marker combination, relates to the technical field of biology, and provides 2014 molecular markers capable of analyzing the features of the varieties of the milk goats, and the physical position information of the molecular markers is compared and determined based on the genome sequence of a goat reference genome ARS1. A molecular probe combination, a gene chip and a kit prepared from the 2014 SNP molecular markers can be used for carrying out genetic evaluation on goat individuals, individual selection is carried out on milk goat varieties which are difficult to measure in the early stage, the generation interval is shortened, the breeding process is accelerated, and therefore a large amount of breeding cost is saved.

The invention belongs to the technical field of biological medicine detection, and particularly relates to an SERS / fluorescent bimodal composite probe, a preparation method and application thereof and a chiral glucose detection method, the composite probe is a gold nanorod modified by a tetraphenylethylene nuclear derivative, and the tetraphenylethylene nuclear derivative is a TPE nuclear molecular probe with AIE attributes; the tetraphenyl ethylene core derivative is prepared by reacting tetrabromo tetraphenyl ethylene with bis (pinacolato) diboron, oxidizing, and reacting with p-mercaptophenylboronic acid. Compared with the prior art, the method has the advantages that the limitations of long time consumption, insufficient sensitivity or specificity deficiency of the traditional chiral molecule identification method in the prior art are solved; and SERS (Surface Enhanced Raman Scattering) and fluorescence analysis are lack of methods and materials suitable for chiral molecule identification. According to the scheme, the composite nanoprobe can form a sandwich structure with molecules of an object to be detected, and rapid detection of chiral glucose is realized according to SERS intensity, fluorescence intensity and color change of the composite nanoprobe.